Emilio Alba-rekin lankidetzan egindako argitalpenak (4)

2018

  1. Male breast cancer: Correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes, and the subsequent clinical outcomes

    Modern Pathology, Vol. 31, Núm. 2, pp. 299-306

  2. Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy

    Oncotarget, Vol. 9, Núm. 41, pp. 26406-26416

2014

  1. Tumor histological subtyping determined by hormone receptors and HER2 status defines different pathological complete response and outcome to dose-dense neoadjuvant chemotherapy in breast cancer patients

    Clinical and Translational Oncology, Vol. 16, Núm. 6, pp. 548-554

2013

  1. The role of immunohistochemistry in breast cancer patients treated with neoadjuvant chemotherapy: An old tool with an enduring prognostic value

    Clinical Breast Cancer, Vol. 13, Núm. 2, pp. 146-152